FDA workgroup considers mHealth regulation

07/22/2013 | Healthcare IT News

A sub-workgroup of the FDA Safety Innovation Act met July 19 to come up with recommendations about whether and how mobile health applications and health IT should be regulated. The group decided that mHealth and HIT should not be subject to FDA oversight with some exceptions, including medical device data systems, medical device accessories that are used with smartphones and some clinical decision support apps or software. The full FDSIA workgroup will consider the recommendations before sending them to the Office of the National Coordinator for Health IT and the FDA.

View Full Article in:

Healthcare IT News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD